share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NARAYEN SHANTANU

Pfizer | 4: Statement of changes in beneficial ownership of securities

辉瑞 | 4：持股变动声明
SEC announcement ·  04/01 13:36
Moomoo AI 已提取核心信息
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on 03/28/2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholdings, were not disclosed in the announcement. As such, the total value of the shares after the action remains unknown. This information is critical for investors who track insider activities as indicators of a company's financial health and future performance.
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on 03/28/2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholdings, were not disclosed in the announcement. As such, the total value of the shares after the action remains unknown. This information is critical for investors who track insider activities as indicators of a company's financial health and future performance.
辉瑞公司 [PFE] 的举报人尚塔努·纳拉延于2024年3月28日参与了一笔交易。公告中未披露交易的具体细节，例如行动类型、状态、所涉股份数量、股票性质、交易价格和交易后的持股情况。因此，行动后股票的总价值仍然未知。这些信息对于追踪内幕活动作为公司财务状况和未来业绩指标的投资者至关重要。
辉瑞公司 [PFE] 的举报人尚塔努·纳拉延于2024年3月28日参与了一笔交易。公告中未披露交易的具体细节，例如行动类型、状态、所涉股份数量、股票性质、交易价格和交易后的持股情况。因此，行动后股票的总价值仍然未知。这些信息对于追踪内幕活动作为公司财务状况和未来业绩指标的投资者至关重要。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息